Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
PCV vaccines
RSV vaccines
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
国电电力 2025年光伏毛利率
Type of publications
Guidelines (1)
NITAG documentation (35)
Reports (3)
SAGE documentation (5)
Scientific publications (2)
Systematic reviews (SYSVAC) (227)
Regions
Africa (18)
Americas (17)
Eastern Mediterranean (10)
Europe (25)
South-East Asia (4)
Western Pacific (14)
Diseases
Chikungunya (4)
Cholera (2)
COVID-19 (70)
Cytomegalovirus (1)
Dengue (1)
Diphtheria (3)
Ebola (1)
Haemophilus influenzae type B (2)
Hepatitis A (2)
Hepatitis B (7)
Hepatitis E (1)
Herpes zoster (7)
Human papillomavirus (HPV) (39)
Influenza (36)
Lyme disease, Borreliosis (1)
Malaria (5)
Measles (9)
Meningococcal disease (6)
Moraxella catarrhalis (1)
Mpox (4)
Mumps (1)
Pertussis (7)
Pneumococcal disease (19)
Poliomyelitis (4)
Rabies (1)
Rotavirus (5)
RSV (Respiratory syncytial virus) (8)
Rubella (1)
Salmonella (1)
Tetanus (4)
Tuberculosis (5)
Typhoid (1)
Varicella (4)
Yellow fever (2)
Show more
273 results found
2025
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against chikungunya in Belgium
2025
∙
NACI
NACI Statement on seasonal influenza vaccines for 2025–2026
2025
∙
Health Council of the Netherlands
COVID-19 vaccination in 2025 in the Netherlands
2025
∙
ATAGI
ATAGI statement on the administration of COVID-19 vaccines in 2025
2025
∙
ATAGI
ATAGI statement on the administration of seasonal influenza vaccines in 2025
2025
∙
NACI
Rapid response: Preliminary guidance on human vaccination against avian influenza in a non-pandemic context as of December 2024
2025
∙
CAVEI
CAVEI recommendation on annual vaccination against COVID-19 for the year 2025
2025
∙
NACI
Guidance on the use of COVID-19 vaccines for 2025 to summer 2026
2025
∙
Global NITAG Network
Standard Operating Procedures of the Global NITAG Network
2024
∙
Haute Autorité de Santé
Transition of INFLUVAC influenza vaccine from its quadrivalent form to a trivalent form in the seasonal influenza vaccination strategy in France
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register